M Zhou, Y Tang, W Xu, X Hao, Y Li, S Huang… - Frontiers in …, 2023 - frontiersin.org
Immunotherapy has been emerging as a powerful strategy for cancer management. Recently, accumulating evidence has demonstrated that bacteria-based immunotherapy …
Spleen tyrosine kinase (SYK) is a critical immune signaling molecule and therapeutic target. We identified damaging monoallelic SYK variants in six patients with immune deficiency …
L Szulc-Dąbrowska, M Bossowska-Nowicka… - Frontiers in cellular …, 2020 - frontiersin.org
Macrophages are the first encounters of invading bacteria and are responsible for engulfing and digesting pathogens through phagocytosis leading to initiation of the innate …
Y Hisham, Y Ashhab - Journal of Immunology Research, 2018 - Wiley Online Library
Brucellosis is a zoonotic infectious disease caused by bacteria of the genus Brucella. Brucella melitensis, Brucella abortus, and Brucella suis are the most pathogenic species of …
JM Pellegrini, JP Gorvel, S Mémet - Microorganisms, 2022 - mdpi.com
Brucellosis is considered one of the major zoonoses worldwide, constituting a critical livestock and human health concern with a huge socio-economic burden. Brucella genus, its …
Immunological interdependence between the two eyes has been reported for the cornea and the retina but not for the ocular mucosal surface. Intriguingly, patients frequently report …
MA Milillo, A Trotta, A Serafino… - Frontiers in …, 2019 - frontiersin.org
Brucella abortus, the causative agent of brucellosis, displays many resources to evade T cell responses conducive to persist inside the host. Our laboratory has previously showed that …
KA Pasquevich, MV Carabajal, FF Guaimas… - Frontiers in …, 2019 - frontiersin.org
Pathogenic microorganisms confront several proteolytic events in the molecular interplay with their host, highlighting that proteolysis and its regulation play an important role during …
LM Coria, LM Saposnik, C Pueblas Castro… - Frontiers in …, 2022 - frontiersin.org
In this work, we evaluated recombinant receptor binding domain (RBD)-based vaccine formulation prototypes with potential for further clinical development. We assessed different …